Lindbrook Capital’s Claritev Corp CTEV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
$144 Buy
+7
New +$139 ﹤0.01% 2734
2024
Q2
Sell
-76
Closed -$2.46K 2847
2024
Q1
$2.46K Buy
76
+35
+85% +$1.47K ﹤0.01% 2166
2023
Q4
$2.35K Sell
41
-31
-43% -$1.88K ﹤0.01% 2208
2023
Q3
$4.81K Buy
72
+3
+4% +$222 ﹤0.01% 1785
2023
Q2
$5.79K Sell
69
-330
-83% -$17.6K ﹤0.01% 1741
2023
Q1
$16.9K Buy
399
+159
+66% +$7.19K ﹤0.01% 1155
2022
Q4
$11K Buy
+240
New +$19.2K ﹤0.01% 1387

Other funds holding CTEV

Lindbrook Capital's CTEV Position: Q1 2025 in Review

Lindbrook Capital opened a new position in Claritev Corp (CTEV) in Q1 2025: 7 shares worth $144. The stake represents ﹤0.01% of the portfolio and ranks #2734 among its holdings. This is a return to the name: Lindbrook Capital previously reported a position in CTEV as recently as Q1 2024.

Lindbrook Capital first reported a position in CTEV in Q4 2022 and has held it in 7 quarters since. The position peaked at $16.9K in Q1 2023. 56 funds tracked by Wall St. Rank hold CTEV as of Q1 2025.

  • Lindbrook Capital held 7 shares of Claritev Corp worth $144 as of Q1 2025.
  • Claritev Corp was a new Lindbrook Capital position in Q1 2025.
  • Claritev Corp made up ﹤0.01% of Lindbrook Capital's portfolio in Q1 2025, its #2734 holding.
  • Lindbrook Capital first reported a position in Claritev Corp in Q4 2022 and has held it in 7 quarters since.
  • Lindbrook Capital's Claritev Corp position peaked at $16.9K in Q1 2023.
  • 56 funds tracked by Wall St. Rank held Claritev Corp as of Q1 2025.

Based on Lindbrook Capital's 13F filing for Q1 2025, filed 5 May 2025.